Company news

CANbridge Pharmaceuticals Inc. news in 2022

CANbridge Pharmaceuticals Inc.'s news releases, calls and decks from 2022, newest first.

View company

CANbridge Announces Financial Results and Corporate Updates for Six Months Ended June 30, 2022

August 25, 2022

CANbridge Forms Scientific Advisory Board to Guide Global Development of CAN106 in Complement-mediated Diseases

July 7, 2022

CANbridge Announces Financial Results and Corporate Updates for the Twelve Months Ended December 31, 2021

March 24, 2022

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA), for Alagille Syndrome, Accepted by China's National Medical Products Administration

January 19, 2022

Decks in 2022